Pritzker Distinguished Lectureship
Through the efforts of the family and friends of Robert Pritzker and the Pritzker Institute of Biomedical Science and Engineering, the Biomedical Engineering Society Distinguished Lecturer Award was renamed in 2007 as a tribute to Robert A. Pritzker (IE ’46, Hon. PhD. ’84). The lectureship was designed to honor Pritzker’s dedication to the advancement of the biological engineering field. The purpose of the lecture is to critically review a field of biomedical engineering and offer a vision of its future.
The Distinguished Lectureship is awarded each year to recognize an individual’s outstanding achievements, originality, and leadership in the science and practice of biomedical engineering. The Pritzker Distinguished Lecturer delivers a plenary talk at the BMES annual conference in the fall, followed by a presentation in the spring, on IIT’s Main Campus.
2011 Pritzker Distinguished Lecture: Michael L. Shuler, "Building a 'Body-On-A-Chip': Towards Better Drug Development"
The Pritzker Institute of Biomedical Science and Engineering is pleased to welcome the 2011 Pritzker Distinguished Lecturer, Cornell University James M. and Marsha McCormick Chair of Biomedical Engineering and Samuel B. Eckert Professor of Chemical Engineering Michael L. Shuler, who will present "Building a 'Body-On-A-Chip': Towards Better Drug Development," at 2 pm on Friday, March 18 in the MTCC Auditorium.
Shuler has been a member of the Cornell faculty since 1974 and has earned two teaching awards. He is a fellow of the American Institute of Medical and Biological Engineers for which he has served as vice president for education. He has received the Amgen Award in biochemical engineering and was elected to membership in the National Academy of Engineers and the American Academy of Arts and Sciences. He is on the editorial boards of four scientific journals.
Shuler's recent research seeks to understand the response of the human body to various pharmaceuticals through the development of a an vitro system that combines microfabrication and cell cultures and is guided by a computer model of the body. This in vitro system is called a micro cell culture analog (microCCA) or a "Body-on-a-Chip".
A microCCA device contains mammalian cells cultured in interconnected micro-chambers to represent key body organs linked through the circulatory system and is a physical representation of a physiologically based pharmacokinetic model. MicroCCAs can reveal toxic effects that result from interactions between organs as well as provide realistic, inexpensive, accurate, rapid throughput toxicological studies that do not require animals. The advantages of operating on a microscale include the ability to mimic physiological relationships more accurately. Microfabricated devices with cell cultures provide a viable alternative to animal models to predict toxicity and efficacy in response to pharmaceuticals.
The Pritzker Institute awards outstanding researchers in the field of biomedical engineering on an annual basis at the Biomedical Engineering Society Annual Meeting, and invites the recipient to visit the Illinois Institute of Technology campus to present his/her work to our community.